The Latest Cardiac and Vascular News
December 8, 2021, San Antonio, TX – Bluegrass Vascular Technologies, a private medical technology company focused on innovating lifesaving devices and methods for vascular access procedures, announced today the publication of a case report demonstrating the ability to utilize the Surfacer® System to perform the Inside-Out® procedure and obtain right-sided central venous access […]
Globally recognized interventional cardiologist is the latest addition to a growing leadership team MIAMI LAKES, Fla., Dec. 9, 2021 /PRNewswire/ — Cordis, a global cardiovascular technology company, today announced George Adams, MD, MHS, MBA, FACC, FSCAI as Chief Medical Officer, furthering the organization’s mission to differentiate itself as a technological leader and value-based […]
December 9, 2021 Philips’ next-generation nSIGHT Plus imaging architecture and new X5-1c Transthoracic Transducer drive breakthrough cardiac imaging performance Debut of AI-enhanced Auto Measure application helps reduce echo quantification time, improving patient and staff experience New remote access with diagnostic confidence on Collaboration Live solution extends the reach and efficiency of ultrasound […]
The innovative software “CAAS vFFR” by Pie Medical Imaging for the non-invasive physiological assessment of intermediate coronary lesions is the subject of FAST III, a multicenter European clinical trial which will investigate the effectiveness of the vessel Fractional Flow Reserve (vFFR) guided revascularization as compared to conventional FFR guided revascularization […]
PITTSBURGH, Dec. 9, 2021 /PRNewswire/ — GPVA announced it had opened two new sites to serve patients in the Pittsburgh region at 1000 Park Place Drive, Suite 201 in Washington, PA and at 27 North Thompson Lane, Suite C, in North Huntingdon, PA. For over two decades, the board-certified physicians and staff at GPVA have been a leading provider […]
BOSTON, Dec. 09, 2021 (GLOBE NEWSWIRE) — Balt, an innovative neurovascular company focused on developing, designing, and manufacturing solutions for treating complex, life-threatening conditions, including stroke, aneurysms, and arteriovenous malformations, today announced the appointment of Jeffrey Sachs as the Company’s Chief Legal & Compliance Officer. Jeffrey Sachs joins the Balt […]
FDA Granted Designation for the Treatment of Symptomatic Obstructive Hypertrophic Cardiomyopathy Based on Results of REDWOOD-HCM SOUTH SAN FRANCISCO, Dec. 09, 2021 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for aficamten for the treatment of symptomatic obstructive […]
Renova Therapeutics Inc, a leader in the development of gene therapies for cardiovascular diseases and diabetes, announced the appointment of Dr. Vijay Mahant to the position of CEO, effective as of Sept. 16, 2021. CARLSBAD, Calif., Dec. 09, 2021 (GLOBE NEWSWIRE) — Dr. Mahant brings a wealth of knowledge and […]
CINCINNATI, Dec. 09, 2021 (GLOBE NEWSWIRE) — CinCor Pharma, Inc. (“CinCor”), announced today the dosing of the first patient in its Phase 2 clinical trial evaluating CIN-107, a highly selective, oral small molecule inhibitor of aldosterone synthase, in patients with uncontrolled hypertension and elevated plasma aldosterone levels, referred to as […]
SILVER SPRING, Md., Dec. 08, 2021 (GLOBE NEWSWIRE) — Aziyo Biologics, Inc. (the “Company”), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, today announced the closing of the previously announced private investment in public equity (PIPE) financing. […]
